User profiles for W.L. Bi

Wenya Linda Bi

Dept. of Neurosurgery, Brigham and Women's Hospital
Verified email at partners.org
Cited by 11792

Artificial intelligence in cancer imaging: clinical challenges and applications

WL Bi, A Hosny, MB Schabath, ML Giger… - CA: a cancer journal …, 2019 - Wiley Online Library
Judgement, as one of the core tenets of medicine, relies upon the integration of multilayered
data with nuanced decision making. Cancer offers a unique context for medical decisions …

Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

…, BG Baumert, MS Berger, WL Bi… - Neuro …, 2023 - academic.oup.com
Isocitrate dehydrogenase (IDH) mutant gliomas are the most common adult, malignant primary
brain tumors diagnosed in patients younger than 50, constituting an important cause of …

A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases

TR Patel, BJ McHugh, WL Bi, FJ Minja… - American journal …, 2011 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Stereotactic radiosurgery is known to control 85%–95% of
intracranial metastatic lesions during a median survival of 6–8 months. However, with the …

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

…, M Al Bakir, E Grönroos, F Zambrana, R Endozo, WL Bi… - Nature, 2017 - nature.com
The early detection of relapse following primary surgery for non-small-cell lung cancer and
the characterization of emerging subclones, which seed metastatic sites, might offer new …

Mechanisms and therapeutic implications of hypermutation in gliomas

…, B Mathon, JS Barnholtz-Sloan, A Chakravarti, WL Bi… - Nature, 2020 - nature.com
A high tumour mutational burden (hypermutation) is observed in some gliomas 1 , 2 , 3 , 4 –
5 ; however, the mechanisms by which hypermutation develops and whether it predicts the …

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study

…, NU Lin, EQ Lee, PY Wen, IF Dunn, WL Bi… - Neuro …, 2017 - academic.oup.com
Background Brain metastases are associated with significant morbidity and mortality.
Population-level data describing the incidence and prognosis of patients with brain metastases are …

Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging

K Chang, HX Bai, H Zhou, C Su, WL Bi, E Agbodza… - Clinical Cancer …, 2018 - AACR
Purpose: Isocitrate dehydrogenase (IDH) mutations in glioma patients confer longer survival
and may guide treatment decision making. We aimed to predict the IDH status of gliomas …

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma

M Abedalthagafi, WL Bi, AA Aizer, PH Merrill… - Neuro …, 2016 - academic.oup.com
Background Meningiomas are the most common primary intracranial tumor in adults.
Identification of SMO and AKT1 mutations in meningiomas has raised the possibility of targeted …

[PDF][PDF] Dissecting the treatment-naive ecosystem of human melanoma brain metastasis

…, H Hibshoosh, A Ribas, P Canoll, JN Bruce, WL Bi… - Cell, 2022 - cell.com
Melanoma brain metastasis (MBM) frequently occurs in patients with advanced melanoma;
yet, our understanding of the underlying salient biology is rudimentary. Here, we performed …

Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas

…, K Chang, S Ramkissoon, S Tanguturi, WL Bi… - Neuro …, 2017 - academic.oup.com
Background. High-grade gliomas with mutations in the isocitrate dehydrogenase (IDH) gene
family confer longer overall survival relative to their IDH-wild-type counterparts. Accurate …